Proctos
ActiveSummary
Proctos has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €234,037 and a net result of €108,773. Equity is growing by about 77% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
- Equity
- €234,037
- Profit
- €108,773
Why 93raises risk2 of the last 3 latelowers riskSize: total assets €254,879Liquidity: current ratio 15.43, cash €106,093Equity €234,037 (91.8% of total assets)Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 95% on liquidity, 90% on profitability and 91% on growth.
The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 3 accounts on average 44 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · micro…
- Highest result from 2023 to 2025net €108,773 ▲29.6%
- Liquidity more than 5 timescurrent ratio 15.43
Financials · financial year 2025, micro format
2023 to 2025, 3 financial years
The operating result has risen two years in a row; 2025 is 32% above 2024 and is the highest result in the available series.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Use the arrow keys on the chart for the figures per year.
Peer companies
Historical observationOf the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.9% are still going.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €4,135 | €9,769 | €9,609 | ▼ 1.6% |
| Other operating charges640/8 | €141 | €914 | €1,206 | ▲ 31.9% |
| Gross operating margin9900 | €50,608 | €117,607 | €151,988 | ▲ 29.2% |
| Operating profit (loss)9901 | €46,332 | €106,924 | €141,173 | ▲ 32.0% |
| Financial income75/76B | - | €26 | - | - |
| Recurring financial income75 | - | €26 | - | - |
| Financial charges65/66B | €696 | €865 | €985 | ▲ 13.8% |
| Recurring financial charges65 | €696 | €865 | €985 | ▲ 13.8% |
| Profit (loss) for the period before taxes9903 | €45,636 | €106,085 | €140,188 | ▲ 32.1% |
| Income taxes67/77 | €9,323 | €22,134 | €31,415 | ▲ 41.9% |
| Profit (loss) for the period9904 | €36,312 | €83,951 | €108,773 | ▲ 29.6% |
| Profit (loss) for the period to be appropriated9905 | €36,312 | €83,951 | €108,773 | ▲ 29.6% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €97,764 | €194,221 | €254,879 | ▲ 31.2% |
| Fixed assets21/28 | €42,372 | €34,169 | €24,559 | ▼ 28.1% |
| Tangible fixed assets22/27 | €42,372 | €34,169 | €24,559 | ▼ 28.1% |
| Plant, machinery and equipment23 | €1,784 | €2,058 | €1,482 | ▼ 28.0% |
| Furniture and vehicles24 | €40,588 | €32,110 | €23,077 | ▼ 28.1% |
| Current assets29/58 | €55,391 | €160,053 | €230,320 | ▲ 43.9% |
| Amounts receivable within one year40/41 | €352 | - | €51,134 | - |
| Trade receivables40 | €352 | - | - | - |
| Other amounts receivable41 | - | - | €51,134 | - |
| Current investments50/53 | - | - | €10,000 | - |
| Cash at bank and in hand54/58 | €28,583 | €111,460 | €106,093 | ▼ 4.8% |
| Deferred charges and accrued income490/1 | €26,456 | €48,592 | €63,093 | ▲ 29.8% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €97,764 | €194,221 | €254,879 | ▲ 31.2% |
| Equity10/15 | €41,312 | €125,263 | €234,037 | ▲ 86.8% |
| Contributions10/11 | €5,000 | €5,000 | €5,000 | = |
| Profit (loss) carried forward14 | €36,312 | €120,263 | €229,037 | ▲ 90.4% |
| Amounts payable17/49 | €56,451 | €68,958 | €20,843 | ▼ 69.8% |
| Amounts payable after more than one year17 | €13,034 | €4,916 | - | - |
| Financial debts170/4 | €13,034 | €4,916 | - | - |
| Amounts payable within one year42/48 | €41,624 | €60,876 | €14,924 | ▼ 75.5% |
| Current portion of amounts payable after more than one year42 | €7,745 | €8,119 | €4,916 | ▼ 39.5% |
| Trade debts44 | €244 | €3,044 | €1,193 | ▼ 60.8% |
| Suppliers440/4 | €244 | €3,044 | €1,193 | ▼ 60.8% |
| Taxes, remuneration and social security45 | €14,054 | €31,739 | €8,815 | ▼ 72.2% |
| Taxes450/3 | €10,454 | €23,339 | €6,415 | ▼ 72.5% |
| Remuneration and social security454/9 | €3,600 | €8,400 | €2,400 | ▼ 71.4% |
| Other amounts payable47/48 | €19,581 | €17,974 | - | - |
| Accrued charges and deferred income492/3 | €1,793 | €3,167 | €5,919 | ▲ 86.9% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | €36,312 | €83,951 | €108,773 | ▲ 29.6% |
| + Depreciation and write-downs630 | €4,135 | €9,769 | €9,609 | ▼ 1.6% |
| Operating cash flow (approximation) | €40,447 | €93,720 | €118,382 | ▲ 26.3% |
| Investment in fixed assets (approximation) | - | -€1,565 | €0 | - |
| Change in cash | - | €82,877 | -€5,367 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (3)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 22-07-2026 | 2026-00318757 |
| 31-12-2024 | micro format | 25-09-2025 | 2025-00506084 |
| 31-12-2023 | micro format | 25-10-2024 | 2024-00516631 |
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| BURY Klara |
|
Owners and capital
Capital and shareholders
- BURY Klara 10 shares (100%) · €5,000 in cash
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 25-07-2023 Incorporation · €5,000 · 10 shares
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
Acts, filings and financial milestones
25-07
Gazette deed
IncorporationAppointment: BURY Klara (director) · Founder · Founding capital6 facts ▸
- Incorporation, “Proctos” (deed in Dutch)
- Founder, BURY Klara
- Founding capital, €5,000
- Shareholding, 17-07-2023, 10
- Director appointment, BURY Klara (director (not named in the articles))
- Pre-incorporation commitments, “takeover, alle verbintenissen,verplichtingen en activiteiten in naam en voor rekening van vennootschap in oprichting” (deed in Dutch)
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 24039B0492/00M000 | Flanders | 1,076 m² | 1 · 158 m² | 7.6 m · 2 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “De vennootschap mag op om het even welke wijze samenwerken met alle verenigingen, rechtspersonen en vennootschappen die een gelijkaardig…” (deed in Dutch)
20 activities (deed in Dutch)
- De vennootschap mag op om het even welke wijze samenwerken met alle verenigingen, rechtspersonen en vennootschappen die een gelijkaardig voorwerp nastreven of die bijdragen tot de algehele of gedeeltelijke verwezenlijking van het voorwerp.
- De vennootschap kan deelnemen in kostenassociaties of middelenvennootschappen van artsen.
- Zij mag deelnemen in alle ondernemingen die een gelijkaardig voorwerp nastreven.
- De vennootschap mag in het algemeen alles doen wat rechtstreeks in verband staat met haar voorwerp, dit alles in overeenstemming met de wetten op de deontologie en de medische plichtenleer, eigen aan het beroep van arts.
- Zij heeft in het algemeen de volle rechtsbekwaamheid om alle handelingen en verrichtingen te voltrekken die een rechtstreeks of onrechtstreeks verband houden met haar voorwerp of welke van die aard zouden zijn dat zij de verwezenlijking van dit voorwerp, rechtstreeks of onrechtstreeks, geheel of ten dele vergemakkelijken.
- Het ter beschikking stellen van alle nodige middelen aan de arts, voor het beheren van een praktijk.
- Het inrichten van algemene diensten, en een medisch secretariaat in het bijzonder, die nuttig of nodig zijn voor de uitoefening van voornoemde activiteiten.
- De vennootschap mag deelnemen aan alle andere vennootschappen die een gelijkaardig voorwerp nastreven of toetreden tot associaties, met dezelfde of aanvullende specialiteiten.
- Overeenkomsten die artsen niet mogen afsluiten met andere artsen of derden, zullen echter ook door de vennootschap niet mogen afgesloten worden.
- Alle inkomsten voortvloeiend uit de medische activiteit worden geïnd voor en door de vennootschap, zoals alle uit de medische activiteit voortvloeiende uitgaven door de vennootschap vereffend worden.
- De aankoop, het huren, het leasen en het invoeren van alle medische apparatuur en begeleidende accommodaties voor voornoemde activiteiten.
- De mogelijkheden scheppen om de arts toe te laten zich verder te bekwamen in zijn discipline, dit teneinde een kwalitatief hoogstaande praktijkuitoefening mogelijk te maken.
- Het occasioneel verstrekken van onderwijs en geven van lezingen over voormelde medische onderwerpen, het schrijven en laten publiceren van medische artikels en boeken, het optreden als stagebegeleider.
- De vennootschap kan zonder afbreuk te doen aan de medische Plichtenleer ter zake, onder het normaal beheer als goede huisvader, een bestemming geven aan haar gereserveerde winsten van welke aard ook.
- De vennootschap kan bijgevolg, als bijkomstig doel, investeringen en beleggingen, zoals onder andere de aankoop, de verhuring en oprichting van gebouwen, uitvoeren die kaderen binnen het normaal patrimoniumbeheer van een burgerlijke vennootschap, zonder dat dit de vorm van een aanvullende commerciële activiteit mag aannemen.
- Zo de vennootschap meerdere vennoten telt, dienen de beslissingen met unanimiteit van de stemmen te gebeuren.
- De uitoefening van de geneeskunde, meer bepaald de beroepsactiviteit van de arts-specialist, door de artsen-aandeelhouders in naam en voor rekening van de vennootschap, in het binnen- en buitenland, volgens de medische plichtenleer en onder de specifieke beroepsaansprakelijkheid van de vennoten, zoals bepaald door de raad van de Orde van Artsen.
- De arts die een patiënt behandelt, zal bijgevolg tegenover deze laatste, als arts persoonlijk aansprakelijk blijven.
- De arts dient verzekerd te zijn voor zijn medische fouten.
- De aansprakelijkheid van de vennootschap dient gewaarborgd te zijn.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Proctos
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Rijkenhoekstraat 38,3191 Boortmeerbeek(Hever)” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- “herroepbare en specifieke volmacht. De volmachtdrager verbindt de vennootschap binnen de noodzakelijk beperkte omvang van zijn mandaat…”
- Board ruleHow the board is made up, meets and takes decisions.
- “Maximaal duur medische activiteit in vennootschap, alle handelingen nodig of dienstig voor voorwerp behoudens alleen algemene vergadering…” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Last Friday of June at 17:00